论文部分内容阅读
目的:探讨超敏C反应蛋白(hs-CRP)在社区获得性肺炎(CAP)患者病情评估中的应用价值。方法:选取2014年1月至2014年12月我院收治的94例CAP患者作为研究对象,比较不同CRUB-65评分组间、重症肺炎与非重症肺炎组hs-CRP水平的差异。结果:不同CRUB-65评分组间hs-CRP水平具有显著差异,hs-CRP水平随着疾病严重程度而逐渐升高(P均<0.05)。与非重症肺炎组相比,重症肺炎组患者hs-CRP水平显著升高,比较有统计学差异(P<0.05)。结论:hs-CRP与CAP的严重程度具有一定相关性,可以作为CAP患者病情评估的重要指标。
Objective: To investigate the value of hs-CRP in the evaluation of patients with community-acquired pneumonia (CAP). Methods: From January 2014 to December 2014, 94 patients with CAP in our hospital were enrolled in this study. The differences of hs-CRP levels between severe pneumonia and non-severe pneumonia were compared between different CRUB-65 scores. Results: There were significant differences in hs-CRP levels between different CRUB-65 scores. The level of hs-CRP was gradually increased with the severity of disease (all P <0.05). Compared with non-severe pneumonia group, the level of hs-CRP in patients with severe pneumonia was significantly increased (P <0.05). Conclusion: There is a certain correlation between hs-CRP and the severity of CAP, which can be used as an important index to evaluate the condition of patients with CAP.